108098-45-9

Upstream product

• 150191-58-5 methyl 2,5-dichloro-3,4-dihydroxybenzoate 
• 99-50-3 3,4-Dihydroxybenzoic acid 

Downstream Products

• 150191-58-5 methyl 2,5-dichloro-3,4-dihydroxybenzoate 
• 108098-46-0 3,4-Diacetoxy-2,5-dichlorobenzoic acid 
• 132496-71-0 4-methoxybenzyl 2,5-dichloro-3,4-bis((4-methoxybenzyl)oxy)benzoate 
• 1225208-52-5 2,5-dichloro-3,4-bis((4-methoxybenzyl)oxy)-N-(2-(pyrrolidin-1-yl)ethyl)benzamide 
• 1225208-51-4 C₃₀H₃₃Cl₂N₇O₁₀S₂ 

Relevant academic research and scientific papers

1, 3-benzodioxole deriv.

The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1,3-b

Piperaziniocephalosporins

Antibacterial hydroxyarylpiperazinocephalosporins of the formula: STR1 wherein R1 is amino or acylamino; R2 is H or methoxy; R3 is alkyl; R4 is --(P--C--Q)n --, where P and Q each are H, alkyl or OH, or P and Q combine to form oxo, and n is 0 or 4; R5 is substituted or unsubstituted hydroxyaryl; R6 has a negative charge and is COO, or an anion in combination with an optionally protected carboxy; and X is O, S or S→O; an antibacterial preparation containing the same; a method for killing bacteria and preventing or treating bacterial infection by using the same; and syntheses of the cephalosporins are provided.

Cephalosporin compounds and their use

A cephalosporin compound of the formula (I): wherein X and Y may be the same or different and are a hydrogen or halogen atom; Z is a hydrogen or halogen atom, -CH=CH2, -CH=CH-CH3, -OR1, -SR2 or -CH2W in which R1 and R2 are a lower alkyl group and W is a hydrogen atom or a nucleophilic residue, its pharmaceutically acceptable salt, a process for preparing the same and their antibacterial composition.